CompoAtlas

Spectra Greens

Retirée du marché américain le 6 January 2025 (selon le DSLD)

DaVinci Laboratories, food supplement from the US market

Label withdrawn from the US market. Spectra Greens (DaVinci Laboratories), a food supplement au code-barres 026664273321, is described by its US market label. If sold in France, it would be subject to 5 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
DaVinci Laboratories
Barcode
026664273321
Form
Powder
One serving
11.88 g
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Apple Flavor, Natural, Cinnamon, Powder
Ingredient (as written, in English)CategoryPer serving
CaloriesOther45 Calorie(s)
Total CarbohydratesCarbohydrate9 Gram(s)
Dietary FiberFibre4 Gram(s)
Total SugarsCarbohydrate2 Gram(s)
ProteinProtein2 Gram(s)
CalciumMineral30 mg
IronMineral1.4 mg
SodiumMineral35 mg
PotassiumMineral80 mg
Proprietary Digestive Support BlendBlend3,415 mg
Fibersol-2Fibrenot stated
FructooligosaccharidesFibrenot stated
BromelainEnzymenot stated
PapainEnzymenot stated
Nondairy Probiotics CultureBlendnot stated
Aloe vera Leaf ExtractPlantnot stated
Licorice, PowderPlantnot stated
Proprietary Detoxification Support BlendBlend4,100 mg
Sunflower Lecithin, PowderFatnot stated
Carrot, PowderPlantnot stated
Grape Seed ExtractPlantnot stated
Parsley Juice, Powder (Petroselinum crispum)Plantnot stated
Broccoli, Powder (Brassica oleracea)Plantnot stated
Alfalfa, Powder (Medicago sativa)Plantnot stated
Cauliflower, PowderPlantnot stated
Blueberry, PowderPlantnot stated
Citrus BioflavonoidsOther substancenot stated
Bilberry Fruit ExtractPlantnot stated
Milk Thistle Extract (Silybum marianum)Plantnot stated
Rosemary, PowderPlantnot stated
Green Tea Extract (Camellia sinensis)Plantnot stated
Proprietary Cardiovascular Support BlendBlend1,700 mg
Apple PectinFibrenot stated
Red Raspberry, Powder (Rubus idaeus)Plantnot stated
Acerola Juice, PowderPlantnot stated
Beet Juice, Powder (Beta vulgaris)Plantnot stated
Flax seed Meal (Linum usitatissimum)Plantnot stated
Rose Hip, Powder (Rosa canina)Plantnot stated
Spinach, PowderPlantnot stated
Cranberry Juice, PowderPlantnot stated
Proprietary Immune System Support BlendBlend435 mg
Royal JellyIngredient of animal originnot stated
Bee PollenIngredient of animal originnot stated
N, N-Dimethylglycine HydrochlorideOther substancenot stated
Eleutherococcus senticosus, Powder (Eleutherococcus senticosus)Plantnot stated
Oat Beta GlucanFibrenot stated
Chlorella, PowderPlant750 mg
SpirulinaPlant500 mg
Stevia Leaf Extract (Stevia rebaudiana)Plant35 mg

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Alfalfa, Powder
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Milk Thistle Extract
    Read the warning, when it applies and the studies cited

    MILK THISTLE - SILYBUM MARIANUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

  • Flax seed Meal
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

  • Royal Jelly
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 24 April 2026

  • Eleutherococcus senticosus, Powder
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Has the product changed? Photograph the packaging.

Brand : DaVinci Laboratories

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line